LFLifecore Biomedical, Inc. LFCR · NASDAQ
$6.44 +0.31% (+$0.02)
- Market cap
- $244.1M
- Enterprise value
- $381.9M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 2.0x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -1.3%
- Gross margin
- 29.7%
- Net margin
- -30.4%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.98
- Free float
- 90.4%
About the company
Lifecore Biomedical, Inc. (LFCR) is an American biotechnology company specializing in the development and manufacturing of medical devices and biopharmaceutical products. The company is known for its expertise in hyaluronic acid and its medical applications, offering products for ophthalmic surgery, orthopedics, and aesthetic medicine. Lifecore Biomedical focuses on innovation and continuous improvement of its products to meet the highest standards of quality and efficiency. Lifecore Biomedical, Inc. (LFCR) shares could be suitable for investors looking for investments in the biotechnology and medical devices sector with an emphasis on innovative and specialized products.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Paul Josephs
Employees
382
Headquarters
Chaska
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: It missed profit estimates 4 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What speaks for it: It has no debt and holds $23.0M in cash.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number